Intravenous and Oral Hydration. Approaches, Principles, and Differing Regimens

Interventional Cardiology Clinics

Volumn 3, Issue 3, 2014, Pages 393-404

  Rojkovskiy, Igor ^a   Solomon, Richard ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Bicarbonate; Contrast induced nephropathy; Forced diuresis; Furosemide; Saline

Indexed keywords

ANTIOXIDANT; BICARBONATE; CONTRAST MEDIUM; FUROSEMIDE; HYPOTONIC SOLUTION; ISOTONIC SOLUTION; MANNITOL; OXYGEN; SODIUM CHLORIDE; WATER;

COMPARATIVE STUDY; CONTRAST INDUCED NEPHROPATHY; DEHYDRATION; DIURESIS; DRUG URINE LEVEL; HIGH RISK PATIENT; HUMAN; HYDRATION; NONHUMAN; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; URINE VOLUME; VISCOSITY;

EID: 84903382918     PISSN: 22117458     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iccl.2014.03.009     Document Type: Review

References (59)

1. Levine G., Bates E.R., Blanenship J.C., et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and Interventions. JAm Coll Cardiol 2011, 58:e44-e122.
2. Stacul F., van der Molen A.J., Reimer P., et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011, 21:2527-2541.
3. Schilp J., de Blok C., Langelaan M., et al. Guideline adherence for identification and hydration of high-risk hospital patients for contrast-induced nephropathy. BMC Nephrol 2014, 15:2. Available at:. http://www.biomedcentral.com/1471-2369/15/2.
4. Andersen K., Christensen E.I., Vik H. Effects of iodinated x-ray contrast media on renal epithelial cells in culture. Invest Radiol 1994, 29:955-962.
5. Heinrich M., Kuhlmann M.K., Grgic A., et al. Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells invitro. Radiology 2005, 235:843-849.
6. Romano G., Briguori C., Quintavalle C., et al. Contrast agents and renal cell apoptosis. Eur Heart J 2008, 29(20):2569-2576.
7. Brezis M., Heyman S.N., Dinour D., et al. Role of nitric oxide in renal medullary oxygenation. Studies in isolated and intact rat kidneys. JClin Invest 1991, 88:390-395.
8. Brezis M., Rosen S., Silva P., et al. Transport activity modifies thick ascending limb damage in the isolated perfused kidney. Kidney Int 1984, 25:65-72.
9. Seeliger E., Flemming B., Wronski T., et al. Viscosity of contrast media perturbs renal hemodynamics. JAm Soc Nephrol 2007, 18(11):2912-2920.
10. Sendeski M., Patzak A., Persson P.B. Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents. Invest Radiol 2010, 45:453-457.
11. Alexander E., Doner D.W., Auld R.B., et al. Tubular reabsorption of sodium during acute and chronic volume expansion in man. JClin Invest 1972, 51:2370-2379.
12. Granger J. Regulation of sodium excretion by renal interstitial hydrostatic pressure. Fed Proc 1986, 45:2892-2896.
13. Speck U. X-ray contrast media: physico-chemical properties. Textbook of contrast media 1999, 35-46. Informa Health Care, Oxford (United Kingdom). P. Dawson, D. Cosgrove, R.G. Grainger (Eds.).
14. Seeliger E., Becker K., Ladwig M., et al. Up to 50-fold increase in urine viscosity with iso-osmolar contrast media in the rat. Radiology 2010, 256:406-414.
15. Ueda J., Nygren A., Hansell P., et al. Effect of intravenous contrast media on proximal and distal tubular hydrostatic pressure in the rat kidney. Acta Radiol 1993, 34:83-87.
16. Ueda J., Furukawa T., Higashino K., et al. Urine viscosity after injections of iotrolan or iomeprol. Acta Radiol 1997, 38:1079-1082.
17. Ueda J., Nygren A., Hansell P., et al. Influence of contrast media on single nephron glomerular filtration rate in rat kidney. Acta Radiol 1992, 33:596-599.
18. Franchini K., Mattson D.L., Cowley A.W. Vasopressin modulation of medullary blood flow and pressure-natriuresis-diuresis in the decerebrated rat. Am J Physiol 1997, 272:R1472-R1479.
19. Larson T., Hudson K., Mertz J.I., et al. Renal vasoconstrictive response to contrast medium: the role of sodium balance and the renin-angiotensin system. JLab Clin Med 1983, 101:385-391.
20. Persson P., Patzak A. Renal hemodynamic alterations in contrast medium-induced nephropathy and the benefit of hydration. Nephrol Dial Transplant 2005, 20(Suppl 1):i2-i5.
21. Erley C., Heyne N., Rossmeier S., et al. Adenosin and extracellular volume in radiocontrast media-induced nephropathy. Kidney Int Suppl 1998, 67:S192-S194.
22. Brezis M., Greenfeld A., Shina A., et al. Angiotensin II augments medullary hypoxia and predisposes to acute renal failure. Eur J Clin Invest 1990, 20:199-207.
23. Sendeski M., Patzak A., Pallone T.L., et al. Iodixanol, constriction of medullary descending vasa recta, and risk for contrast medium-induced nephropathy. Radiology 2009, 251:697-704.
24. Yoshioka T., Fogo A., Beckman J.K. Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletion. Kidney Int 1992, 41:1008-1015.
25. Tumkur S., Vu A.T., Pierchala L., et al. Evaluation of intra-renal oxygenation during water diuresis: a time-resolved study using bold MRI. Kidney Int 2006, 70:139-143.
26. Prasad P.V., Edelman R.R., Epstein F.H. Noninvasive evaluation of intrarenal oxygenation with bold MRI. Circulation 1996, 94:3271-3275.
27. Li L.P., Franklin T., Du H., et al. Intrarenal oxygenation by blood oxygenation level-dependent MRI in contrast nephropathy model: effect of the viscosity and dose. JMagn Reson Imaging 2012, 36(5):1162-1167.
28. Spitalewitz S., Chou S.Y., Faubert P.F., et al. Effects of diuretics on inner medullary hemodynamics in the dog. Circ Res 1982, 51:703-710.
29. Saikia T. Composition of the renal cortex and medulla of rats during water diuresis and antidiuresis. Exp Physiol 1965, 50:146-157.
30. Atherton J., Thomas S. Effect of 0.9% saline infusion on urinary and renal tissue composition in the hydropaenic, normal and hydrated conscious rat. JPhysiol 1970, 210:45-71.
31. Bartels E.D., Brun G.C., Gammeltof A., et al. Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta Med Scand 1954, 150:297-302.
32. Kerstein M.D., Puyau F.A. Value of periangiography hydration. Surgery 1984, 96:919-922.
33. Anto H.R., Chou S.Y., Porush J.G., et al. Infusion, intravenous pyelography and renal function. Effect of hypertonic mannitol in patients with chronic renal insufficiency. Arch Intern Med 1981, 141:1652-1656.
34. Chen S., Zhang J., Yei F., et al. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine. Int J Cardiol 2008, 126:407-413.
35. Maioli M., Toso A., Leoncini M., et al. Effects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trial. Circ Cardiovasc Interv 2011, 4:456-462.
36. Cho R., Javed N., Traub D., et al. Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease. JInterv Cardiol 2010, 23:460-466.
37. Kong D., Hou Y.F., Ma L.L., et al. Comparison of oral and intravenous hydration strategies for the prevention of contrast-induced nephropathy in patients undergoing coronary angiography or angioplasty: a randomized clinical trial. Acta Cardiol 2012, 67:565-569.
38. Lawlor D., Moist D.K., Derose L., et al. Prevention of contrast-induced nephropathy in vascular surgery patients. Ann Vasc Surg 2007, 21:593-597.
39. Trivedi H.S., Moore H., Nasr S., et al. Arandomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003, 93:c29-c34.
40. Wrobel W., Sinkiewicz W., Gordon M., et al. Oral versus intravenous hydration and renal function in diabetic patients undergoing percutaneous coronary interventions. Kardiol Pol 2010, 68:1015-1020.
41. Dussol B., Morange S., Loundoun A., et al. Arandomized trial of saline hydration to prevent contrast nephropathy in chronic renal failure patients. Nephrol Dial Transplant 2006, 21:2120-2126.
42. Yoskikawa D., Isobe S., Sato K., et al. Importance of oral fluid intake after coronary computed tomography angiography: an observational study. Eur J Radiol 2011, 77:118-122.
43. Taylor A.J., Hotchkiss D., Morse R.W., et al. PREPARED: Preparation for Angiography in Renal Dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Chest 1998, 114:1570-1574.
44. Bader B.D., Berger E.D., Heede M.B., et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?. Clin Nephrol 2004, 62:1-7.
45. Krasuski R.A., Beard R.M., Geoghagan J.D., et al. Optimal timing of hydration to erase contrast-associated nephropathy: the other CAN study. JInvasive Cardiol 2003, 15:699-702.
46. Mueller C., Buerkle G., Buettner H., et al. Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angiography. Arch Intern Med 2002, 162:329-336.
47. Marron B., Ruiz E., Fernandez C., et al. Systemic and renal effects of preventing contrast nephrotoxicity with isotonic (0.9%) and hypotonic (045%) saline. Rev Esp Cardiol 2007, 60:1018-1025.
48. Majumdar S., Kjellstrand C.M., Tymchak W.J., et al. Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial. Am J Kidney Dis 2009, 54:602-609.
49. Solomon R., Werner C., Mann D., et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. NEngl J Med 1994, 331:1416-1420.
50. Weinstein J.M., Heyman S., Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 1992, 62:413-415.
51. Gu G., Lu R., Cui W., et al. Low-dose furosemide administered with adequate hydration reduces contrast-induced nephropathy in patients undergoing coronary angiography. Cardiology 2013, 125:69-73.
52. Barlak A., Akar H., Yenicerioglu Y., et al. Effect of sodium bicarbonate in an experimental model of radiocontrast nephropathy. Ren Fail 2010, 32:992-999.
53. Wardman P., Candeias L.P. Fenton chemistry; an introduction. Radiat Res 1996, 145:523-531.
54. Hoste E., De Waele J.J., Gevaert S.A., et al. Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systemic review and meta-analysis. Nephrol Dial Transplant 2010, 25:747-758.
55. Wiedermann C., Joannidis M. Increasing evidence base for sodium bicarbonate therapy to prevent contrast media-induced acute kidney injury: little role of unpublished studies. Nephrol Dial Transplant 2010, 25:650-654.
56. Brar S., Hhiremathy S., Dangas G., et al. Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2009, 4:1584-1592.
57. Stevens M.A., McCullough P.A., Tobin K., et al. Aprospective randomized trial of prevention measures in patients at high risk for contrast nephropathy. JAm Coll Cardiol 1999, 33:403-411.
58. Marenzi G., Ferrari C., Assanelli E., et al. Furosemide-induced diuresis with matched replacement of intravascular volume compared to standard hydration for contrast-induced nephropathy prevention: the Mythos trial. Circulation 2009, 120:S1003. [abstract].
59. Briguori C., Visconti G., Focaccio A., et al. Renal insufficiency after contrast media administration trial II (remedial II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury. Circulation 2011, 124(11):1260-1269.